Abstract
A validated method based on liquid chromatography/positive ion electrospray–mass spectrometry (LC-ESI/MS) is described for the quantification of perindopril and its active metabolite, perindoprilat, in human plasma. The assay was based on 500-μL plasma samples, following solid-phase extraction using Oasis HLB cartridges. All analytes and the internal standard (trandolapril) were separated by hydrophilic interaction liquid chromatography using a SeQuant Zic-HILIC analytical column (150.0 × 2.1 mm i.d., particle size 3.5 μm, 200 Å) with isocratic elution. The mobile phase consisted of 10% 5.0 mM ammonium acetate water solution in a binary mixture of acetonitrile/methanol (60:40, v/v) and pumped at a flow rate of 0.10 mL min−1. Quantitation of the analytes was performed with selected ion monitoring (SIM) in positive ionization mode using electrospray ionization interface. The assay was found to be linear in the concentration range of 5.0–500.0 ng mL−1 for perindopril and perindoprilat. Intermediate precision were found less than 3.5% over the tested concentration ranges. A run time of less than 6.0 min for each sample made it possible to analyze a large number of human plasma samples per day. The method is the first reported application of HILIC in the analysis of angiotensin-converting enzyme inhibitors and can be used to quantify perindopril and perindoprilat in human plasma covering a variety of pharmacokinetic or bioequivalence studies.
Similar content being viewed by others
References
Lerebours G, Antony I (1994) Can J Cardiol 10(suppl D):3–7
Zhuo JL, Mendelsohn FA, Ohishi M (2002) Hypertension 39:634–638
Todd PA, Fitton A (1991) Drugs 42:90–114
Curran MP, McCormack PL, Simpson D (2006) Drugs 66:235–255
Hillaert S, Vander-Heyden Y, van-den-Bossche WJ (2002) J Chromatogr A 978:231–242
Erk N (2001) J Pharm Biomed Anal 26:43–52
Medenica M, Ivanović D, Mašković M, Jančić B, Malenović A (2007) J Pharm Biomed Anal 44:1087–1094
Rudzki PJ, Buś K, Ksycińska H, Kobylińska K (2007) J Pharm Biomed Anal 44:356–367
Tsaconas C, Devissaguet M, Padieu P (1989) J Chromatogr Biomed Appl 488:249–265
Doucet L, De Veyrac B, Delaage M, Cailla H, Bernheim C, Devissaguet M (1990) J Pharm Sci 79:741–745
Van Den Berg H, Resplandy G, De Bie ATHJ, Floor W, Bertrand M, Arts CJM (1991) J Pharm Biomed Anal 9:517–524
Ezan E, Morge X, Lelievre E, Creminon C, Piraube C, Grognet JM (1993) Ther Drug Monit 15:448–454
Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Komarneni P (2006) Rapid Commun Mass Spectrom 20:1864–1870
Deepak SJ, Subbaiah G, Sanyal M, Pande UC, Shrivastav P (2006) J Chromatogr B 837:92–100
Alpert A (1990) J Chromatogr 499:177–196
Gheorge A, van Nuijs A, Pecceu B, Bervoets L, Jorens PG, Blust R, Neels H, Covaci A (2008) Anal Bioanal Chem 391:1309–1319
Van Platerink CJ, Janssen HGM, Haverkamp J (2008) Anal Bioanal Chem 391:299–307
Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Anal Chem 75:3019
Boersema PJ, Mohammed S, Heck AJR (2008) Anal Bioanal Chem 391:151–159
Hemström P, Irgum K (2006) J Sep Sci 29:1784–1821
Grumbach ES, Wagrowski-Diehl DM, Mazzeo JR, Alden B, Iraneta PC (2004) LC GC N Am 22:1010–1023
Guo Y, Gaiki S (2005) J Chromatogr A 1074:71–80
Guidance for industry. Bioanalytical method validation. FDA May 2001 http://www.fda.gov/cder/guidance/4252fnl.pdf
Acknowledgments
The Special Account for Research Grants, University of Athens, Greece supported this work financially. The authors gratefully acknowledge Dr. Dimitra Gennimata, Pharmacist PhD, Sotiria General Hospital, Athens, Greece for providing the patient’s plasma sample.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Georgakakou, S., Kazanis, M. & Panderi, I. Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma. Anal Bioanal Chem 397, 2161–2170 (2010). https://doi.org/10.1007/s00216-010-3551-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3551-9